Nutritional aspects regarding lung cancer chemoprevention

Journal of B.U.ON.

Volumn 11, Issue 1, 2006, Pages 7-20

  Thanopoulou, Eirini ^a,d   Baltayiannis, N ^b   Lykogianni, V ^c  

^a HAROKOPIO UNIVERSITY   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

^c Department of Physiology   (France)

^d NONE   (Greece)

Author keywords

Carcinogenesis; Chemoprevention; Diet; Lung cancer; Nutrition; Retinoids

Indexed keywords

ACETYLCYSTEINE; ALITRETINOIN; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ANTINEOPLASTIC AGENT; BETA CAROTENE; BEXAROTENE; CALCIUM; CAROTENOID; ETRETIN; FENRETINIDE; GENISTEIN; ISOFLAVONE DERIVATIVE; ISOTHIOCYANIC ACID DERIVATIVE; ISOTRETINOIN; LIMONENE; LYCOPENE; PERILLYL ALCOHOL; POLYPHENOL DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOID DERIVATIVE; RETINOID X RECEPTOR; RETINOL DERIVATIVE; RETINOL PALMITATE; SELENIUM; SULFUR DERIVATIVE; TERPENE DERIVATIVE; TRACE ELEMENT; UNINDEXED DRUG; VITAMIN D;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTHRALGIA; ARTICLE; BASIC RESEARCH; BONE DISEASE; BONE FRAGILITY; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CENTRAL NERVOUS SYSTEM DISEASE; CIGARETTE SMOKING; CLINICAL STUDY; CLINICAL TRIAL; DERMATITIS; DIET THERAPY; DNA SYNTHESIS INHIBITION; DRUG ABSORPTION; DRUG RECEPTOR BINDING; DRUG TISSUE LEVEL; DRY SKIN; DYSPEPSIA; EYE TOXICITY; FOOD COMPOSITION; FOOD INTAKE; FRACTURE; HEADACHE; HUMAN; HYPEROSTOSIS; HYPERTRIGLYCERIDEMIA; INFORMATION PROCESSING; LIGAMENT CALCINOSIS; LIVER DYSFUNCTION; LUNG CANCER; LUNG CARCINOGENESIS; MACRONUTRIENT; MEDICAL LITERATURE; MEDLINE; MUCOSAL DRYNESS; NAUSEA; NUTRITIONAL SUPPORT; PHOTOSENSITIVITY DISORDER; PROTEIN SYNTHESIS INHIBITION; PUBLISHING; REVIEW; RISK REDUCTION; SKIN ABRASION; SKIN EXFOLIATION; SKIN PRURITUS; SKIN TOXICITY; TERTIARY HEALTH CARE; VISUAL IMPAIRMENT;

EID: 33646706559     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. Reis L, Eisner M, Kosary C et al. SEER Cancer Statistics Review, 1973-1997. Bethesda, Md: National Cancer Institute, 2000.
2. Schottenfield D. Epidemiology of lung cancer. In: Pass HI, Mitchell JB, Johnson DH, (eds): Lung Cancer: Principles and Practice. Philadelphia, Pa: Lippincott-Raven; 1996, pp 305-321.
3. Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976; 36: 2699-2702.
4. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278: 1073-1077.
5. Mao LM, El-Naggar A, Papadimitrakopoulou V et al. Phenotype and genotype of advanced premalignant lesions after chemopreventive therapy. J Natl Cancer Inst 1998; 90: 1545-1551.
6. Bartsch H, Petruzzelli S, De Flora S et al. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case-control multicenter study on lung cancer patients. Environ Health Perspect 1992; 98: 119-124.
7. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral cavity stratifies squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
8. Doll R, Peto R. The causes of cancer: qualitative estimates of available risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191-1308.
9. National Academy of Sciences: C.o.D.N.a.C. Diet, Nutrition and Cancer. Washington, DC, National Academy Press, 1982.
10. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991; 2: 325-357.
11. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-29.
12. Ziegler R, Colavito E, Hartge P. Importance of alpha-carotene, beta-carotene, and other phytochemicals in the etiology of lung cancer. J Natl Cancer Inst 1996; 88: 612-615.
13. Colditz GA, Stampfer MJ, Willett WC. Diet and lung cancer. A review of the epidemiologic evidence in humans. Arch Intern Med 1987; 147: 157-160.
14. Byers T. Diet as a factor in the etiology and prevention of lung cancer. In: Samet J (ed): Epidemiology of lung cancer. New York: Marcel Dekker, 1994, pp 335-352.
15. Stahelin H, Gey K, Eichholzer M. Plasma anti-oxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel study. Am J Epidemiol 1991; 133: 766-775.
16. Nomura AM, Stemmermann G, Heilbrun L. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res 1985; 45: 2369-2372.
17. Wald NJ, Thompson S, Densem J et al. Serum beta-carotene andsubsequent risk of cancer: results from the BUPA study. Br J Cancer 1988; 57: 428-433.
18. Virtamo J, Valkeila E, Alfthan G. Serum selenium and risk of cancer. A prospective follow-up of nine years. Cancer 1987; 60: 145-148.
19. Connett JE, Kuller L, Kjelsberg M. Relationship between carotenoids anticancer. The Multiple Risk Factor Intervention Trial (MRFIT) study. Cancer 1989; 64: 126-134.
20. Kelloff GJ, Boone CW. Cancer chemopreventive agents: Drug development status and future prospects. J Cell Biochem (Suppl) 1995; 22: 1-262.
21. Sinha R, Kulldorff M, Swanson CA, Curtin J, Brownson RC, Alavan MC. Dietary heterocyclic amines and the risk of lung cancer among Missouri women. Cancer Res 2000; 60: 3753-3756.
22. Spitz MR, Duphorne CM, Detry MA et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione transferase polymorphisms in lung cancer risk in current smokers. Cancer Epidemiol Biomarkers Prevent 2000; 9: 1017-1020.
23. Feskanich D, Ziegler RG, Michaud DS et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000; 92: 1812-1823.
24. Woodson K, Stewart C, Barrett M et al. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers. Cancer Epidemiol Biomarkers Prevent 1999; 8: 965-970.
25. Shen H, Spitz MR, Wang LE et al. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prevent 2001; 10: 397-401.
26. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS (eds): Retinoids: Biology, Chemistry, and Medicine (2nd edn). New York, NY: Raven Press, 1994, pp 319-349.
27. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-954.
28. Zelent A, Mendelsohn C, Kastner P et al. Differentially expressed isoforms of the mouse retinoic acid receptor beta are generated by usage of two promoters and alternative splicing. EMBO J 1991; 10: 71-81.
29. Napgal S, Zelent A, Chambon P. RAR-beta 4, a retinoic acid receptor isoform is generated from RAR-beta 2 by alternative splicing and usage of a CUG initiator codon. Proc Natl Acad Sci USA 1992; 89: 2718-2722.
30. Dragnev KH, Rigas JR, Dmitrovsky E. The retinoids and cancer prevention mechanisms. Oncologist 2000; 5: 361-368.
31. Lotan R, Xu XC, Lippman SM et al. Suppression of retinoic acid receptor p in premalignant oral lesions and its upregulation by isotretinoin. N Engl J Med 1995; 332: 1405-1410.
32. Singh DK, Lippman SM. Cancer chemoprevention. Part 1: retinoids and carotenoids and other classic antioxidants. Oncology (Huntingt) 1998; 12: 1643-1653, 1657-1660.
33. IARC Working Group on the Evaluation of Cancer Preventive Agents. IARC handbooks of cancer prevention. In: Retinoids 1999; 4: IARC, Lyon, France, p 331.
34. Soria JC, Moon C, Wang L et al. Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. J Natl Cancer Inst 2001; 93: 1257-1263.
35. Kurie JM, Lotan R, Lee JJ et al. Randomized, placebo-controlled trial of 9-cis retinoic acid (9cRA) versus 13-cis retinoic (13 cRA) plus alpha tocopherol (AT) in the reversal of biomarkers of bronchial preneoplasia in former smokers. Proc Am Soc Clin Oncol 2002; 21: 295(abstr #1177).
36. Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene 2001; 20: 7140-7145.
37. Khuri FR, Rigas JR, Figlin RA et al. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer. J Clin Oncol 2001; 19: 2626-2637.
38. Lippman SM, Heyman RA, Kurie JM. Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem 1995; 22: 1-10.
39. Arora A, Willhite CA, Liebler DC et al. Interactions of β-carotene and cigarette smoke in human bronchial epithelial cells. Carcinogenesis 2001; 22: 1173-1178.
40. Van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J Natl Cancer Inst 2000; 92: 977-986.
41. Lippman SM, Lee JJ, Karp DD et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001; 93: 605-618.
42. Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep 1987; 71: 493-515.
43. Smith MA, Parkinson DR, Cheson BD et al. Retinoids in cancer therapy. J Clin Oncol 1992; 10: 839-864.
44. Dimery IW, Hong WX, Lee JJ et al. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann Oncol 1997; 8: 85-89.
45. Costa A, Forrnelli F, Chiesa F et al. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res 1994; 54: 2032S-2037S.
46. Mariani L, Formelli F, De Palo G et al. Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalmologic tolerability. Tumori 1996; 82: 444-449.
47. Brooks AD, Tong W, Benedetti F, Kaneda Y, Miller V, Warrell RP. Inhaled aerosolization of all-trans-retinoic acid for targeted pulmonary delivery. Cancer Chemother Pharmacol 2000; 46: 313-318.
48. McLaughlin JK, Hrubec Z. Smoking and cancer mortality among US veterans: a 26-year follow-up. Int J Cancer 1995; 6: 190-193.
49. Alpha Tocopherol Beta Carotene Trial Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035.
50. Omenn GS, Goodman GE, Thornquist M et al. The beta-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high-risk populations: smokers and asbestos-exposed workers. Cancer Res 1994; 54: 2038-2043.
51. Omenn GS, Goodman GE, Thornquist M et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550-1559.
52. Albanes D, Heinonen OP, Taylor PR et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of baseline characteristics and study compliance. J Natl Cancer Inst 1996; 88: 1560-1570.
53. Burton GW, Ingold KU. beta-Carotene: an unusual type of lipid antioxidant. Science 1984; 224: 569-573.
54. Omenn GS. Chemoprevention of lung cancer: the rise and demise of beta-carotene. Annu Rev Public Health 1998; 19: 73-99.
55. Wang XD, Liu C, Bronson RT et al. Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999; 91: 60-66.
56. Liu C, Wang XD, Bronson RT et al. Effects on physiological versus phar-malogical β-carotene supplementation on cell proliferation and histopath-ological changes in the lungs of cigarette smoke-exposed ferrets.Carcinogenesis 2000; 21: 2245-2253.
57. Handelman GJ, Parker L, Cross CE et al. Destruction of tocopherols,carotenoids and retinol in human plasma by cigarette smoke. Am J ClinNutr 1996; 63: 559.
58. Baker DL, Krol ES, Jacobsen N et al. Reactions of β-carotene with cigarette smoke oxidants. Identification of carotenoid oxidation products andevaluation of the prooxidant/antioxidant effect. Chem Res Toxicol 1999; 12: 535-543.
59. Stahl W, Sies H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 1996; 336: 1-9.
60. Clinton SK, Emenhiser C, Schwartz S. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate: Cancer Epidemiol Biomarkers Prev 1996; 5: 823-833.
61. Kim DJ, Takasuka N, Nishino H et al. Chemoprevention of lung cancer by lycopene. Biofactors 2000; 13: 95-102.
62. Kim DJ, Takasuka N, Kim JM et al. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. Cancer Lett 1997; 120: 15-22.
63. Schwartz J, Shklar G. The selective cytotoxic effect of carotenoids and alpha-tocopherol on human cancer cell lines in vitro. J Oral Maxillofac Surg 1992; 50: 367-374.
64. Woodson K, Tangrea JA, Barrett MJ et al. Serum α-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999; 91: 1738-1743.
65. Combs GF Jr, Combs SB. Selenium and cancer. In: Combs GF Jr, Combs SB (eds): The Role of Selenium in Nutrition. San Diego, CA: Academic Press, 1986, pp 413-462.
66. Patterson BH, Levander OA. Naturally occurring selenium compounds in cancer chemoprevention trials: a workshop summary. Cancer Epidemiol Biomark Prev 1997; 6: 63-69.
67. Knekt P, Aromaa A, Maatela J, Alfthan G et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990; 82: 864-868.
68. Knekt P, Marniemi J, Teppo L, Heliovaara M, Aromaa A. Is low selenium status a risk factor for lung cancer? Am J Epidemiol 1998; 148: 975-982.
69. Knekt P, Jarvinen R, Seppanen R et al. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol 1991; 134: 471-479.
70. van den Brandt PA, Goldbohm RA, van 't Veer P et al. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 1993; 53: 4860-4865.
71. Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF. Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 1988; 128: 515-523.
72. Kabuto M, Imai H, Yonezawa C et al. Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomark Prev 1994; 3: 465-469.
73. Comstock GW, Alberg AJ, Huang HY et al. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, a-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomark Prev 1997; 6: 907-916.
74. Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum /3-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986; 315: 1250-1254.
75. Clark LC, Combs GF Jr, Turnbull BW et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. JAMA 1996; 276: 1957-1963.
76. Reid ME, Duffield AJ, Garland L et al. Selenium supplementation and lung cancer incidence: an update of the Nutritional Prevention of Cancer trial. Cancer Epidemiol Biomarkers Prev 2002; 11: 1285-1291.
77. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res 2001; 475: 123-139.
78. Fiala ES, Staretz ME, Pandya GA, El-Bayoumy K, HamiltonSR. Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis 1998; 19: 597-604.
79. Redman C, Xu MJ, Peng YM et al. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 1997; 18: 1195- 1202.
80. Merlo A, Herman JG, Mao L et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686-692.
81. Hecht SS. Chemoprevention of lung cancer by isothiocyanates. Advan Exp Med Biol 1996; 401: 1-11.
82. Spitz MR, Duphorne CM, Detry MA et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione transferase polymorphisms in lung cancer risk in current smokers. Cancer Epidemiol Biomarkers Prevent 2000; 9: 1017-1020.
83. Hong YS, Ham YA, Choi JH, Kim J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp Mol Med 2000; 32: 127-134.
84. Fujiki H, Suganuma M, Okabe S et al. Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat Res 2001; 480-481: 299-304.
85. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-1155.
86. Findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1988; 318: 262-264.
87. Hennekens CH, Buring JE, Manson JE et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149.
88. Auerbach O, Gere JB, Forman JB et al. Changes in the bronchial epithelium in relation to smoking and cancer of the lung. N Engl J Med 1957; 256: 98-104.
89. Auerbach O, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. N Engl J Med 1979; 300: 381-386.
90. Auerbach O, Stout AP, Hammond EC et al. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961; 265: 253-267.
91. Gouveia J, Hercend T, Lemaigre G et al. Degree of bronchial metaplasia in heavy smokers and its regression after treatment with a retinoid. Lancet 1982; 1: 710-712.
92. Mathe G, Gouveia J, Hercend R et al. Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. Cancer Detect Prev 1982; 5: 461-466.
93. Heimberger DC, Alexander CB, Birch R et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12: report of a preliminary randomized double-blind intervention trial. JAMA 1988; 259: 1525-1530.
94. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol 1994; 12: 851-873.
95. Arnold AM, Browman GP, Levine MN et al. The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomized trial. Br J Cancer 1992; 65: 737-743.
96. Lee JS, Lippman SM, Benner SE et al. A randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994; 12: 937-945.
97. Kurie JM, Lee JS, Khuri ER et al. N-(4-Hydroxyphenyl)-retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 2000; 6: 2973-2979.
98. McLarty JW, Holiday DB, Girard WM et al. Beta-carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 1995; 62: 1431S-1438S.
99. Lippman SM, Batsakis JG, Toth BB et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328: 15-20.
100. Kurie JM, Lotan R, Lee JJ et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst 2003; 95: 206-214.
101. Decker J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med 1982; 306: 1151-1155.
102. Boice JD, Fraumeni JF. Second cancer following cancer of the respiratory system in Connecticut, 1935-1982. Natl Cancer Inst Monogr 1985; 68: 83-98.
103. De Vries N, Snow GB. Multiple primary tumours in laryngeal cancer. J Laryngol Otol 1986; 100: 915-918.
104. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993; 328: 184-193.
105. Cohen MD, Fadlo R, Khun MD. Progress in Lung Cancer Chemoprevention. Cancer Control 2003; 10: 315-324.
106. Pastorino U, Infante M, Maioli M et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin Am J Clin Oncol 1993; 11: 1216-1222.
107. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II - a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000; 10: 125-134.
108. Hercberg S, Preziosi P, Briancon S et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics. SUpplementation en VItamines et Mineraux AntioXidants. Control Clin Trials 1998; 19: 336-351.
109. Lee IM, Cook NR, Manson JE et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91: 2102-2106.
110. Winterhalder RC, Hirsch FR, Kotantoulas GK et al. Chemoprevention of lung cancer-from biology to clinical reality. Ann Oncol 2004; 15: 185-196.
111. Taylor P, Greenwald P. Nutritional Interventions in Cancer Prevention. J Clin Oncol 2005; 23: 333-345.
112. O'Shaughnessy JA, Kelloff GJ, Gordon GB et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002; 8: 314-346.
113. Fahey JW, Zhang YS, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 1997; 94: 10367-10372.